Ligand Pharmaceuticals (NASDAQ:LGND) Announces Quarterly Earnings Results, Beats Expectations By $0.56 EPS
Ligand Pharmaceuticals (NASDAQ:LGND - Get Free Report) posted its quarterly earnings data on Thursday. The biotechnology company reported $2.02 earnings per share (EPS) for the quarter, beating the...